Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MILLS, Gordon B")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 110

  • Page / 5
Export

Selection :

  • and

AMPK: A Contextual Oncogene or Tumor Suppressor?JIYONG LIANG; MILLS, Gordon B.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 10, pp 2929-2935, issn 0008-5472, 7 p.Article

Bayesian models based on test statistics for multiple hypothesis testing problemsYUAN JI; YILINQ LU; MILLS, Gordon B et al.Bioinformatics (Oxford. Print). 2008, Vol 24, Num 7, pp 943-949, issn 1367-4803, 7 p.Article

Of spiders and crabs: The emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancerMURPH, Mandi; TAMOTSUTANAKA; LIU, Shuying et al.Clinical cancer research. 2006, Vol 12, Num 22, pp 6598-6602, issn 1078-0432, 5 p.Article

XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cellsASSELIN, Eric; MILLS, Gordon B; TSANG, Benjamin K et al.Cancer research (Baltimore). 2001, Vol 61, Num 5, pp 1862-1868, issn 0008-5472Article

Targeting the Hepatocyte Growth Factor―cMET Axis in Cancer TherapyBLUMENSCHEIN, George R; MILLS, Gordon B; GONZALEZ-ANGULO, Ana M et al.Journal of clinical oncology. 2012, Vol 30, Num 26, pp 3287-3296, issn 0732-183X, 10 p.Article

Future of Personalized Medicine in Oncology: A Systems Biology ApproachGONZALEZ-ANGULO, Ana Maria; HENNESSY, Bryan T. J; MILLS, Gordon B et al.Journal of clinical oncology. 2010, Vol 28, Num 16, pp 2777-2783, issn 0732-183X, 7 p.Article

Serial dilution curve : a new method for analysis of reverse phase protein array dataLI ZHANG; QINGYI WEI; LI MAO et al.Bioinformatics (Oxford. Print). 2009, Vol 25, Num 5, pp 650-654, issn 1367-4803, 5 p.Article

Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activityLIAN QIAN; YONG XU; HASEGAWA, Yutaka et al.Journal of medicinal chemistry (Print). 2003, Vol 46, Num 26, pp 5575-5578, issn 0022-2623, 4 p.Article

Identification of Optimal Drug Combinations Targeting Cellular Networks: Integrating Phospho-Proteomics and Computational Network AnalysisLADEVAIA, Sergio; YILING LU; MORALES, Fabiana C et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 17, pp 6704-6714, issn 0008-5472, 11 p.Article

Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagyFUJIWARA, Keishi; IWADO, Eiji; MILLS, Gordon B et al.International journal of oncology. 2007, Vol 31, Num 4, pp 753-760, issn 1019-6439, 8 p.Article

Emerging role of RAB GTPases in cancer and human diseaseCHENG, Kwai W; LAHAD, John P; GRAY, Joseph W et al.Cancer research (Baltimore). 2005, Vol 65, Num 7, pp 2516-2519, issn 0008-5472, 4 p.Article

Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer modelsLIMIN HU; HOFMANN, Judith; YILING LU et al.Cancer research (Baltimore). 2002, Vol 62, Num 4, pp 1087-1092, issn 0008-5472Article

Differences in Gene and Protein Expression and the Effects of Race/Ethnicity on Breast Cancer SubtypesCHAVEZ-MACGREGOR, Mariana; SHUYING LIU; MERIC-BERNSTAM, Funda et al.Cancer epidemiology, biomarkers & prevention. 2014, Vol 23, Num 2, pp 316-323, issn 1055-9965, 8 p.Article

Proteomic Characterization of Breast Cancer Xenografts Identifies Early and Late Bevacizumab-Induced Responses and Predicts Effective Drug CombinationsLINDHOLM, Evita M; KROHN, Marit; IADEVAIA, Sergio et al.Clinical cancer research (Print). 2014, Vol 20, Num 2, pp 404-412, issn 1078-0432, 9 p.Article

An Epithelial―Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor ResistanceAVERETT BYERS, Lauren; LIXIA DIAO; NILSSON, Monique B et al.Clinical cancer research (Print). 2013, Vol 19, Num 1, pp 279-290, issn 1078-0432, 12 p.Article

cMET and Phospho-cMET Protein Levels in Breast Cancers and Survival OutcomesRAGHAV, Kanwal P; WENTING WANG; SHUYING LIU et al.Clinical cancer research (Print). 2012, Vol 18, Num 8, pp 2269-2277, issn 1078-0432, 9 p.Article

Src Inhibition with Saracatinib Reverses Fulvestrant Resistance in ER-Positive Ovarian Cancer Models In Vitro and In VivoSIMPKINS, Fiona; HEVIA-PAEZ, Pedro; AZZAM, Diana et al.Clinical cancer research (Print). 2012, Vol 18, Num 21, pp 5911-5923, issn 1078-0432, 13 p.Article

A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast CancerFOX, Emily M; MILLER, Todd W; SHYR, Yu et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 21, pp 6773-6784, issn 0008-5472, 12 p.Article

3-Phosphoinositide-Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast CarcinomaMAURER, Matthew; TAO SU; CHIN, Y. Rebecca et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 15, pp 6299-6306, issn 0008-5472, 8 p.Article

Akt1 and Akt2 Play Distinct Roles in the Initiation and Metastatic Phases of Mammary Tumor ProgressionDILLON, Rachelle L; MARCOTTE, Richard; HENNESSY, Bryan T et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 12, issn 0008-5472, 5057-5064 [8 p.]Article

A Vascular Targeted Pan Phosphoinositide 3-Kinase Inhibitor Prodrug, SF1126, with Antitumor and Antiangiogenic ActivityGARLICH, Joseph R; DE, Pradip; SHU, H-K et al.Cancer research (Baltimore). 2008, Vol 68, Num 1, pp 206-215, issn 0008-5472, 10 p.Article

Lysophosphatidic Acid Receptors Determine Tumorigenicity and Aggressiveness of Ovarian Cancer CellsSHUANGXING YU; MURPH, Mandi M; YILING LU et al.Journal of the National Cancer Institute. 2008, Vol 100, Num 22, pp 1630-1642, issn 0027-8874, 13 p.Article

Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinomaROSEN, Daniel G; GONG YANG; DEAVERS, Michael T et al.Cancer. 2006, Vol 106, Num 9, pp 1925-1932, issn 0008-543X, 8 p.Article

G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growthZHU, Quan-Sheng; LING XIA; MILLS, Gordon B et al.Blood. 2006, Vol 107, Num 5, pp 1847-1856, issn 0006-4971, 10 p.Article

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates AktO'REILLY, Kathryn E; ROJO, Fredi; BASELGA, Jose et al.Cancer research (Baltimore). 2006, Vol 66, Num 3, pp 1500-1508, issn 0008-5472, 9 p.Article

  • Page / 5